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Background: Despite extensive research, a direct correlation between low to moderate prenatal alcohol exposure
(PAE) and Fetal Alcohol Spectrum Disorders has been elusive. Conflicting results are attributed to a lack of accurate
and detailed data on PAE and incomplete information on contributing factors. The public health effectiveness of
policies recommending complete abstinence from alcohol during pregnancy is challenged by the high frequency
of unplanned pregnancies, where many women consumed some alcohol prior to pregnancy recognition. There is a
need for research evidence emphasizing timing and dosage of PAE and its effects on child development.
Methods/Design: Asking QUestions about Alcohol (AQUA) is a longitudinal cohort aiming to clarify the complex
effects of low to moderate PAE using specifically developed and tested questions incorporating dose, pattern and
timing of exposure. From 2011, 2146 pregnant women completed a questionnaire at 8-18 weeks of pregnancy.
Further prenatal data collection took place via a questionnaire at 26-28 weeks and 35 weeks gestation. Extensive
information was obtained on a large number of risk factors to assist in understanding the heterogeneous nature of
PAE effects. 1571 women (73%) completed all three pregnancy questionnaires. A biobank of DNA from maternal
and infant buccal cells, placental biopsies and cord blood mononuclear cells will be used to examine epigenetic
state at birth as well as genetic factors in the mother and child. Participants will be followed up at 12 and 24
months after birth to assess child health and measure infant behavioural and sensory difficulties, as well as family
environment and parenting styles. A subgroup of the cohort will have 3D facial photography of their child at 12
months and a comprehensive developmental assessment (Bayley Scales of Infant & Toddler Development, Bayley-III)
at two years of age.
Discussion: Using detailed, prospective methods of data collection, the AQUA study will comprehensively examine
the effects of low to moderate alcohol consumption throughout pregnancy on child health and development,
including the role of key mediators and confounders. These data will ultimately contribute to policy review and
development, health professional education and information about alcohol consumption for pregnant women in
the future.
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It is well recognised that heavy and chronic alcohol con-
sumption in pregnancy is associated with Fetal Alcohol
Spectrum Disorder (FASD), a major preventable cause
of health and developmental problems in children. FASD
encompasses generalised neurodevelopmental impair-
ments including lower IQ, attention difficulties, memory
problems, slow processing speed, executive dysfunction,
and emotional-behavioural problems [1,2]. There are,
however, conflicting reports of the effect of low to mod-
erate doses of prenatal alcohol exposure (PAE) and any
putative association is complex as it is difficult to separ-
ate aetiological effects of PAE from other variables that
influence childhood behaviour [3-10]. Further, the het-
erogeneity in findings has in part been attributed to the
difficulty in capturing and categorising low to moderate
PAE accurately [3,11-13].
Public health significance
The lack of clarity on the effects of low to moderate
PAE has resulted in policies and guidelines that recom-
mend complete abstinence from alcohol during preg-
nancy as the safest option [14,15]. The public health
effectiveness of this approach is limited by the high fre-
quency of unplanned pregnancies, with many women
having consumed alcohol around the time of conception
and even well into the pregnancy before knowing they
were pregnant [16-18]. Therefore, there is a need for evi-
dence to better inform pregnant women about the impact
of PAE in this critical stage of embryonic development, par-
ticularly for low to moderate exposures.
Objectives
1) To survey mothers at each trimester of pregnancy
using a new approach to measure dose and timing
of low to moderate alcohol consumption, while
collecting important co-factors that are likely to
influence outcomes associated with PAE.
2) To survey mothers at 12 and 24 months postpartum
to measure parental report of offspring health and
development.
3) To collect biosamples at birth for the study of
genetic and epigenetic factors in relation to
measurements of offspring health and development.
4) To conduct clinical assessments of children at
12 months (facial morphology) and at 24 months
(neurodevelopment) in a representative sub-sample
of participants from each PAE group.
Hypothesis
Facial dysmorphology (measured at 12 months of age)
and neurodevelopmental delay (measured at 24 months)
represent a continuum of subtle fetal alcohol effects, andwill be evident in young children exposed to low and
moderate doses of alcohol in the first trimester of preg-
nancy. Such effects will be exacerbated or ameliorated
by explanatory factors, including epigenetics.
Methods
Study design and study population
AQUA (Asking QUestions about Alcohol) is a longitudinal
cohort study designed by Australian researchers who are
expert in the field of pregnancy alcohol research, clinical
care, epidemiology, genetics, epigenetics, craniofacial
analysis, neurodevelopment and FASD.
All women making their first appointment for ante-
natal care at one of seven metropolitan public hospitals
between 25 July 2011 and 30 July 2012 were eligible to
participate in the study if they were less than 19 weeks
gestation, aged 16 years or older, sufficiently proficient
in English to complete the questionnaires and had a
singleton pregnancy.
Specially trained recruitment staff provided a detailed
explanation of the prospective nature of the study, in-
cluding information on an optional consent for biospeci-
mens (maternal and/or infant buccal swab, cord blood,
placental biopsy) and permission to access hospital rec-
ord birth information. Following written informed con-
sent, participants provided a buccal swab and were given
the option of completing the first questionnaire (Q1) on
site or at home.
Table 1 shows the population of pregnant women pre-
senting for their first appointment while our recruitment
staff were in attendance (n = 11732). A total of 6944
women were not approached as they were either ineli-
gible, missed in clinic, in another study, had a non-viable
pregnancy, or were considered unsuitable to approach,
e.g. having had a recent fetal loss. Almost 4,800 women
were approached about the study. The recruitment of
abstinent women ceased in April 2012, when the target
number was achieved; hence 457 women were not in-
vited to participate when they volunteered information
about alcohol abstinence. A further 58 women were not
invited because they were moving interstate, overseas or
were scheduled to deliver in a non-study hospital.
Of those approached, 1238 (27%) declined to partici-
pate. In total, 3035 consented to participate, 2146 of
whom completed questionnaire 1 (Q1) (71.0%). Of these,
2034 women gave permission to a buccal swab (94.8%),
82.5% to collection of cord blood and placental biopsies
at birth, 85.4% to infant buccal swabs and 91.2% to med-
ical records access.
Table 2 divides the non-participating population into
three groups, those who declined, those who consented
but did not go on to complete Q1 and a mixture of
those not approached or not asked to participate for
various reasons as stated above. Participating women
Table 1 AQUA cohort recruitment in antenatal clinics; 25 July 2011 to 31 July 2012
Clinic Clinic 1 Clinic 2 Clinic 3 Clinic 4 Clinic 5 Clinic 6 Clinic 7 Total
Women approached Participated and completed Questionnaire 1 242 190 99 563 472 478 106 2146
Did not participate (reason):
Declined; too busy; not interested 136 91 185 127 235 412 52 1238
Consented, but never returned any questionnaires 93 82 95 197 174 156 88 889
Abstinent or no alcohol in lifetime* 65 29 0 62 87 207 7 457
Moving interstate/overseas; delivering elsewhere 5 0 2 5 5 40 1 58
Women not
approached
Over 18 weeks gestation 59 58 28 297 421 2797 133 3793
Less than 16 years of age 1 0 0 1 0 4 1 7
Multiple pregnancy 11 0 1 23 47 6 1 89
Not enough English** 124 75 187 333 253 610 42 1624
Pregnancy not viable 2 0 1 0 0 7 0 10
Missed in clinic 65 25 16 110 186 579 140 1121
Already in other research 13 0 0 147 1 37 2 200
Midwife decision not to approach 5 8 2 14 8 59 4 100
Total 821 558 616 1879 1889 5392 577 11 732
*recruitment of abstinent women ceased on April 12, 2012, when target number was achieved.
**includes three pregnant women with either a hearing, vision or intellectual impairment.
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groups, and less likely to be in the lowest socioeconomic
quartile when compared with non-participants. Women
who participated were also slightly more advanced in
gestation at their first visit than those who initially con-
sented but never returned Q1.
Data collection
There are six time points at which data are collected.
(Table 3).
Pregnancy to birth (this stage is completed)
During pregnancy, participants completed three ques-
tionnaires: questionnaire1 (Q1) at 12-18 weeks, ques-
tionnaire 2 (Q2) at 26-28 weeks, and questionnaire 3
(Q3) at 35 weeks gestation. A paper version of Q1 wasTable 2 Baseline characteristics of pregnant women at AQUA
Variable Participants
(n = 2,146)
D
(
Maternal age, mean (SD) 31.3 (0.1) 3
Gestational age at first visit, mean (SD) 14.1 (0.1) 1
Socioeconomic index ;£ lowest quartile 117 5.6% 1
Socioeconomic index; second quartile 305 14.5% 1
Socioeconomic index; third quartile 635 30.3% 3
Socioeconomic index; fourth quartile (highest) 1042 49.6% 5
*This column comprises all women who were not approached (Table 1), 58 women
after April 12, 2012 because they were either lifetime abstainers or had not consum
£Index of Relative Socio-economic Disadvantage: A general socio-economic index s
conditions of people and households within a geographic area. The index was calcu
Bureau of Statistics.
§p < 0.001 when compared to participants, 2-sample t test.
‡p < 0.001 when compared to participants, chi 2.included in a recruitment pack. Participants were able to
choose between online and paper follow-up; approxi-
mately two thirds of the cohort chose to complete sub-
sequent questionnaires online.
Staff attempted to attend all births that occurred after
37 weeks gestation to collect biospecimens (where con-
sent was provided). An on-call roster system, daily birth
suite lists and clinical staff assisted collection. If staff
were unavailable for specimen collection at birth, two
buccal swabs were posted to the mother with instruc-
tions on how to collect cheek cells from her infant
within 28 days of birth; almost 80% of infant buccals
were collected using this method.
Birth outcome data were obtained by accessing elec-
tronic medical records. Selected variables were down-
loaded by a hospital staff member then forwarded to therecruitment sites; 25 July 2011 to 31 July 2012
eclined
n = 1,238)
Consented, but never
participated (n = 889)
Not eligible, missed,
other* (n = 7459)
0.5 (0.1)§ 30.1 (0.2)§ 30.4 (0.1)§
4.2 (0.1) 13.6 (0.1)§ N/A
29‡ 11.2% 65 8.0% 704‡ 10.1%
79 15.5% 102 12.5% 989 14.1%
37 29.2% 256 31.5% 1889 27.0%
08 44.1% 391 48.0% 3416 48.8%
who delivered elsewhere and 457 women who were not invited to participate
ed any alcohol since becoming pregnant or planning to be pregnant.
ummarising and ranking a range of information about the economic and social
lated from the 2011 Census of Population and published by the Australian
Table 3 Summary of participant follow-up and data collection
Follow up timing Year Who is invited? What is the nature
of follow-up?
What is being measured?
12-18 weeks gestation 2011-2012 All participants: Questionnaire 1; Maternal buccal Demographics, obstetric history,
current pregnancy dates,
health, alcohol & other lifestyle,
family & relationships
Alcohol metabolism
26 weeks gestation 2011-2012 All participants: Questionnaire 2 Diet, health, alcohol & other lifestyle
35 weeks gestation 2011-2013 All participants: Questionnaire 3 Obstetric complications health,
alcohol & other lifestyle
Birth 2011-2013 All participants: Access to hospital records; Placenta,
cord blood, infant buccal
Perinatal information Infant epigenetics
12 months after birth 2013-2014 All participants: Questionnaire 4 Birth and coping, breast feeding, child health,
child development, health, alcohol & other lifestyle,
family & relationships, combining work & family
Subset of participants: 3D photography of child’s face Craniofacial morphometrics
24 months after birth 2014-2015 All participants: Questionnaire 5 Child health, child development, health,
alcohol & other lifestyle, family & relationships,
combining work & family
Subset of participants: Developmental assessment Detailed child development
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(97.2% of those consented). Some participants were un-
able to be matched to hospital records because of in-
accurate information on their patient record number or
where they gave birth at a different hospital than where
they had booked for care.
Figure 1 shows the flow of participants through the
AQUA study from recruitment to birth. Attrition be-
tween Q1 and Q2 was 20.3% with 1715 participantsFigure 1 AQUA cohort participation and attrition from enrolment tocompleting both questionnaires. Further attrition of
8.4% occurred between Q2 and Q3 and 1571 partici-
pants completed all three pregnancy questionnaires.
There was less than 1% attrition between Q3 and birth,
resulting in 1566 active participants at completion of
pregnancy, 1491 (95.2%) of whom provided a maternal
buccal swab. The final biobank contains 248 placental
biopsies, 210 cord blood samples and 738 infant buccal
swabs. Table 4 details the reasons for attrition atbirth. *89.4% (n = 1405) with hospital birth information.
Table 4 AQUA cohort attrition between pregnancy questionnaires
Reason for attrition After Q1 After Q2 After Q3 Birth
Dropped-out (loss to follow-up) 383 138
Withdrew 11 3 3
Fetal loss 18 2 2
Administrative reason (e.g. scheduling error) 19 1
Total n = 586 431 144 5
Table 5 Number of Participants by alcohol exposure
group
Prenatal alcohol exposure group Participants (%)
No alcohol in lifetime 112 (7.1)
Abstinent throughout pregnancy 495 (31.5)
Abstinent in trimester 1, no more than moderate
in trimesters 2 and 3
56 (3.6)
Low in trimester 1, abstinent in trimesters 2 and 3 147 (9.4)
Moderate in trimester 1 abstinent in
trimesters 2 and 3
146 (9.3)
Low to moderate in trimester 1, no more than
moderate in trimesters 2 and 3
254 (16.2)
High in any or all trimesters, incl. binge on special
occasions
178 (11.3)
No more than moderate in any or all trimesters,
with binge on special occasions pre-aware
99 (6.3)
Total 1570* (100)
*Excluding one participant whose PAE was unable to be categorised due to
lack of information.
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reason for attrition was loss to follow-up and a small
percentage of women actively withdrew their participa-
tion on follow-up (3% of reasons overall). Some women
experienced a fetal loss, most early in pregnancy, and
20 participants were withdrawn for administrative rea-
sons, such as lost forms or scheduling errors.
After birth (this stage is in progress)
Questionnaires are completed when the children are
12 months (Q4) and 24 months (Q5) and a subgroup
of approximately 75% of the children (up to 150 per
exposure group) are sequentially invited for clinical as-
sessments at 12 months (craniofacial) and 24 months
(neurodevelopmental).
Variables
Pregnancy alcohol exposure (PAE)
Following extensive development of the PAE assessment
(literature review, expert consultations, focus groups,
pilot questions) [19] a set of questions, accompanied by
a visual guide, was included in all questionnaires to
measure PAE. Assessment of PAE was divided into five
time points; at 12 weeks prior to conception, from
conception but prior to pregnancy recognition, since
pregnancy recognition to gestational week 14, from ges-
tational week 15 to week 25, and from gestational week
25 to (at least) week 36 or birth, whichever occurred
first. Drinking type, volume, pattern and frequency for
each stage of pregnancy was converted to absolute
alcohol (AA) and categorised as abstinent (no alcohol
consumed); low (≤20gAA/occasion, and <70gAA/week);
moderate (21-49gAA/occasion, and ≤ 70gAA/week ); or
high (>70gAA/week, including binge with ≥50gAA/occa-
sion) [11]. One standard drink in Australia is equal to
10 g of alcohol. Final exposure groups were defined
using a modified algorithm developed in another related
study [11] and participants were allocated to one of eight
PAE groups (Table 5).
Outcome measures
a) Questionnaire data Primary outcome measures are
health and physical development at birth and at
12 months and neurodevelopment at 12 and 24 months.
Questionnaire 4 at 12 months and Questionnaire 5 at24 months collect information relating to sensory pro-
cessing, functional performance and social-emotional-
behavioural issues and competencies of the child. The
Infant/Toddler Sensory Profile (ITSP) [20] is a 48-item
parent-report questionnaire that assesses sensory pro-
cessing, as well as determining specific sensory profile
patterns. Emotional and behavioural problems of the
child are assessed using the Brief Infant Toddler Social
Emotional Assessment (BITSEA), [21] a reliable and
valid screen for emotional and behavioural problems and
delays in social competence. The Children with Special
Health Care Needs Screener is used to identify if any
children have one or more functional limitations or ser-
vice needs as a result of an on-going health condition
[22]. This information on child health is complemented
by study-specific questions on number and type of hos-
pitalisations, birth defects and one general question on
overall child health.b) Clinical assessments Forming the clinical review
group are participants reporting a range of PAE, plus a
maximum of 150 sequentially selected controls (those
who were abstinent throughout pregnancy), who agree
to clinical assessments at 12 and/or 24 months of age.
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the children are captured [23]. Previous research found
a difference in minor facial anomalies between infants
born to women who abstained from alcohol and women
with low alcohol intake [24]. We are using 3D imaging
to analyse detailed facial morphometrics amongst the
major PAE groups to identify subtle manifestations of
PAE not evident clinically.
At 24 months of age, the clinical review group is offered
a neurodevelopmental assessment of their child. This
involves administration of the Bayley Scales of Infant
and Toddler Development, Third Edition (Bayley-III), [25]
which is the most widely used measure of developmental
delay in clinical and research settings. The Bayley-III
provides an objective assessment of cognitive, language
(expressive and receptive), and motor (fine and gross) de-
velopment, and will be administered by psychologists in the
hospital setting who are trained to use this scale.Contextual factors
Careful consideration was given to inclusion of relevant
contextual factors previously reported in the literature to
influence these outcomes, either as confounders, effect
modifiers or mediators (Figure 2). Specific instruments
and other measures previously reported in the literature
were used where possible, to assess contextual factors as
well as outcomes (Table 6).Figure 2 Contexual factors and primary outcome measures of the AQa) Confounders Factors reported in the literature to be
both predictors of PAE and adverse child outcomes as-
sociated with PAE, but not on the causal pathway are:
maternal age 30 years and older; [26] pregnancy wanted-
ness; [27] increasing parity [28] and obstetric history
[3]. Further potential confounders collected as repeated
measures across all questionnaires include maternal psy-
chological wellbeing, [26-30] smoking, [28,31,32] illicit
substances, [27,33] medication and supplement use, par-
ticularly folate [14,34]. Several factors are measured in Q4
(at 12 months after birth), providing proxy measures for
unknown antecedent confounding factors. These are ma-
ternal depression, the postnatal care-giving environment
(based on family structure and parenting style) [26,31],
current maternal and partner tobacco and substance use
[26] and social disadvantage [35].
Metabolic processes that modify blood alcohol levels
have been shown to be highly variable among individ-
uals, pointing to underlying genetic and environmental
differences [36]. Genetic factors, specifically polymor-
phisms in the alcohol dehydrogenase (ADH) gene family,
increase alcohol elimination rates thereby reducing fetal
alcohol toxicity by lowering the maternal blood level
more quickly than usual [37]. Variants in alcohol meta-
bolising genes also influence a person’s level of alcohol con-
sumption and risk for alcoholism [38]. Further, family
history data and ethnic differences in alcohol sensitivity
point towards a substantial role for genetic polymorphismsUA study.
Table 6 Overview of instruments and measures used in the AQUA study (under copyright and/or published)
Items Questionnaire 1 Questionnaire 2 Questionnaire 3 Questionnaire 4 Questionnaire 5
Family history of
alcohol problems
Family Tree
questionnaire (FTQ)
(modified) [60]
Maternal
psychological well
being
Assessment of
Quality of Life
(AQoL-6D) [61]
AQoL-6D AQoL-6D AQoL-6D; Depression Anxiety Stress Scales (DASS, 21 items); [62] Mother-to-Infant Bond-
ing Scale [63]
DASS
Diet Dietary Questionnaire for
Epidemiological Studies
(DQES v2)†
Family structure &
relationships
McMaster Family Assessment Device (General Functioning Subscale; [64] LSAC
Reciprocal Support for Parenting, Argumentative relationship; [65] List of Threatening
Experiences (modified); [66] Quality of Co-parental Interaction Scale (Conflict Subscale)
[65,67]
As in
Questionnaire 4
Parenting style Global rating of self-efficacy; [65] Child Rearing Questionnaire (6/30 items); [65,68] Hos-
tile Parenting Scale [69]
As in
Questionnaire 4
Social
disadvantage
Social risk index; [52] LSAC Social Support and Community Connectedness; [65] As in
Questionnaire 4
Child health Children with Special Health Care Needs Screener (CSHCN) [22] As in
Questionnaire 4
Neurodevelopment Brief Infant Toddler Social Emotional Assessment (BITSEA);†† Infant/Toddler Sensory
Profile (ITSP)†††
As in
Questionnaire 4
†The authors thank Professor Graham Giles of the Cancer Epidemiology Centre of The Cancer Council Victoria, for permission to use the Dietary Questionnaire for Epidemiological Studies (Version 2), Melbourne: The
Cancer Council Victoria, 1996.
††Infant-Toddler Social and Emotional Assessment (BITSEA). Copyright © 2000 Yale University and University of Massachusetts. Computer adaptation Copyright © 2012 Yale University and University of Massachusetts.
Reproduced with permission of the publisher NCS Pearson, Inc. All rights reserved.
†††Infant/Toddler Sensory Profile. Copyright © 2002 NCS Pearson, Inc. Computer adaptation Copyright © 2012 NCS Pearson, Inc. Adapted and reproduced with permission. All rights reserved.
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pregnancy outcomes [39]. Therefore, maternal and paternal
ethnicity were collected in Q1 and genetic polymorphisms
(eg ADH1B) [40] are assessed in maternal buccal DNA.
b) Effect modifiers We will also consider effect modi-
fiers not directly associated with prenatal alcohol use,
but potentially altering the effect of PAE. These are ma-
ternal body composition and diet and the child’s sex
[28,41]. Self-reported measures of pre-pregnancy body
composition were collected in Q1. A food frequency
questionnaire was completed to assess dietary micro-
and macronutrient intake as part of Q2 and details of
the child’s sex was obtained via hospital birth record
linkage.
c) Mediators Epigenetic regulation may be an important
mediator on the causal pathway between alcohol expos-
ure and child outcomes [42,43], reviewed in [44]. Animal
studies have shown that PAE leads to changes in global
DNA methylation levels and methylation at specific
genes, in particular imprinted genes, which are under-
stood to be particularly sensitive to environmental fac-
tors [45-48]. DNA methylation will be measured in
DNA from infant buccal cells, cord blood mononuclear
cells and placental biopsies at gene-specific, global and
genome-wide levels.
Further, adverse perinatal outcomes such as preterm
birth, small head circumference, low Apgar scores and
low birth weight have been associated with high dose al-
cohol consumption [3,32,49] and could be intermediate
variables on the causal pathway between PAE and neu-
rodevelopmental problems. Perinatal information was
obtained from hospital birth record linkage and in Q4.
Sample size considerations
Facial morphometrics
150 participants in six exposure groups will have 80%
power to detect a difference of 0.33 standard deviations
between mean values in the abstinent group compared
with the exposed groups (effect size of 0.33). Our mea-
sures are based on those shown to distinguish between
partial FAS and controls [50]. In a related study, [51] the
effect sizes for these measures were estimated for FAS
versus controls: minimal frontal breadth 0.7, bitragal
breadth 0.6, midfacial depth 0.6, total facial height 0.4.
Effect sizes for partial FAS (low to moderate doses) are
expected to be smaller.
Neurodevelopmental assessments
At 12 months of age, there will be high power to detect
clinically significant differences in parent report measures
of child social, emotional and sensory development, with
150 available in each PAE group. At 24 months of age, with150 children in each group being clinically reviewed using
the Bayley III, there will be 80% power to detect a differ-
ence of 0.33 between groups. As the Bayley has a mean of
100 and SD 15, this effect size equates to a difference of 5
points on the scale, a clinically important difference.
Statistical methods
The effect of different levels of PAE on facial morpho-
metrics and neurodevelopmental assessment scores will
be investigated using multivariable linear regressions
with alcohol exposure group as a categorical predictor
variable. A selection of the possible confounders will
be included as independent variables in the regression
models - in this analysis of low and moderate PAE, even
distribution of many of the confounders across PAE
groups can be expected. Adjustments will only be made
where groups are unbalanced. In addition, it is likely that
there will be a high degree of correlation between many
of the possible confounders. If necessary, we will reduce
the list of confounders to a smaller group of relatively
independent variables through investigation of the cor-
relation patterns, and through grouping techniques such
as with the Social Risk Index [52].
Ethical approval
The establishment of the AQUA study was approved by
the Eastern Health Research and Ethics Committee
(E54/1011) and the Human Research Ethics Committees
of Mercy Health (R11/14), Monash Health (11071B), the
Royal Women’s Hospital (11/20) and the Royal Chil-
dren’s Hospital (31055A). The latter also approved all
follow-up of the children (31055C/D).
Discussion
This longitudinal cohort study seeks to provide new evi-
dence on the complex effects of low to moderate alcohol
consumption in pregnancy on early child development
by utilising a specifically developed and tested set of
questions on alcohol intake. Findings are expected to
show how far key mediators and confounders may con-
tribute to the association between PAE and child health
and development. Contradictory findings of other stud-
ies may be attributed to different or inadequate mea-
sures of timing, pattern of use and dose of alcohol
consumption. To assess a potential effect of even the
lowest levels of prenatal alcohol consumption, we have
chosen two reliable early outcomes (facial morphomet-
rics and Bayley-III) which are also feasible and cost-
effective in a research setting spanning four years.
As part of our collaboration with expert scientists, cli-
nicians and policy makers at State and Federal Govern-
ment level, it is planned that we will seek consent for
record linkage to school entrance health and develop-
ment assessments. Further funding will also be sought
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important mediator in the effect of prenatal alcohol on
child outcomes.
Results of this study are expected to substantially contrib-
ute to policy review and development, health professional
education and consumer information about alcohol con-
sumption for pregnant women in the future. Information
will be particularly relevant to anxious women who have
consumed alcohol before knowing they were pregnant.Strengths and weaknesses
The key strength of the AQUA study lies in its prospect-
ive exposure assessment through use of specifically de-
veloped and tested questions on alcohol intake that
assess timing, pattern of use and dose of alcohol con-
sumption. Our facial morphometric and neurodevelop-
mental measures are suitable for use in a clinical setting,
thereby having the potential to assist in the preclinical
diagnosis of FASD, allowing for early treatment to min-
imise adverse secondary outcomes in later life. We have
chosen detailed assessments of emotion and behaviour,
as well as cognition, language and motor functioning,
these being typically affected in children with FASD.
Another novel aspect of this study is the examination of
sensory functioning. Development is largely dependent
on sensory experiences, and challenges in the process-
ing and integration of sensory information may be a
marker for later neurodevelopmental problems. Over-
all, the combination of questionnaire and hospital rec-
ord data, clinical assessments and an ability to make
correlations with genetic and epigenetic data from
stored biospecimens place the study in a unique pos-
ition to investigate the effect of low to moderate PAE.
We are also able to specify PAE prior to pregnancy rec-
ognition, a critical phase of embryonic development
and before most women cease or reduce their alcohol
consumption.
A limitation of any study measuring PAE is that there
are currently no validated objective measures to detect
low to moderate exposure. Ethanol metabolites in mater-
nal urine, hair or umbilical blood and meconium sam-
ples have been used to identify moderate to heavy
drinkers around the time of birth with reasonable cer-
tainty; [53-55] however, absence of these biomarkers
does not provide definite evidence of abstinence. There-
fore, we must depend on accurate maternal recall and
reporting. However, our focus group work (paper in
preparation) indicated that women would answer as ac-
curately as possible, due to their vested interest in the
outcomes of this study examining what may be consid-
ered normal, non-risky drinking habits.
Further, the validity of some covariates (e.g. body mass,
diet, smoking and other lifestyle factors including paternalexposures) may be subject to reporting bias due to a desire
to provide socially acceptable responses [56,57].
While certain facial phenotypes are known to be asso-
ciated with prenatal alcohol exposure, it is likely that age
and ethnicity play a role in our assessment of facial fea-
tures. To remove a potential age effect, 3D images were
captured within two weeks of the child’s birthday. How-
ever, it may be difficult to determine whether some fea-
tures can directly be attributed to PAE if our population
is ethnically diverse [51,58].
A proportion of children identified with early develop-
mental delay will catch up to peers over time, while
some children who are developing age appropriately in
early childhood, will encounter problems for the first
time later in childhood with increasing demand for
higher-order cognitive skills. It is known that the Bayley
Scales are moderately predictive of later outcomes, [59]
which is to be expected given the inter-individual vari-
ability in developmental trajectories.
Finally, in instances where there is no clinical review
of the child, we depend on maternal report using vali-
dated scales to determine child developmental progress.
Although we are using widely accepted and validated
scales, maternal subjective assessments introduce in-
formant bias.
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